Nontransvenous Cardiovascular Implantable Electronic Device Technology—A Review for the Anesthesiologist

There has been a recent shift in bradycardia pacing and defibrillation therapy to leadless pacemakers and extrathoracic cardioverter-defibrillator technology due to complications associated with transvenous devices. These innovations have implications for anesthesia care, as these novel devices have...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiothoracic and vascular anesthesia 2021-09, Vol.35 (9), p.2784-2791
Main Authors: Cody, Joseph, Graul, Thomas, Holliday, Scott, Streckenbach, Scott, Hussain, Nasir, Dalia, Adam A., Cronin, Brett, Hargrave, Jennifer, Augoustides, John G., Essandoh, Michael
Format: Article
Language:English
Subjects:
Anesthesiologists
Defibrillators, Implantable
Electronics
EMPOWER leadless pacemaker
Humans
Micra
Non-transvenous cardiovascular implantable electronic devices
Pacemaker, Artificial
Subcutaneous implantable cardioverter-defibrillator
Technology
WiSE CRT system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There has been a recent shift in bradycardia pacing and defibrillation therapy to leadless pacemakers and extrathoracic cardioverter-defibrillator technology due to complications associated with transvenous devices. These innovations have implications for anesthesia care, as these novel devices have design and functionality features different from transvenous devices. Current perioperative guidelines do not address management of leadless pacemakers and the subcutaneous implantable cardioverter-defibrillator, although implantation rates are increasing globally. This article addresses the features and capabilities of nontransvenous cardiac implantable electronic devices, such as the Micra and the subcutaneous implantable cardioverter-defibrillator, and provides guidance for perioperative management.
ISSN:1053-0770
1532-8422
DOI:10.1053/j.jvca.2021.02.018